Health Condition 1: G- Mental Health
Conditions
Interventions
Intervention1: Mobile-Based Intervention for Treatment Adherence in Chronic Mental Illness - Schizophrenia.: A smartphone application that provides medication reminders, symptom tracking, motivational
Sponsors
Saveetha medical college and hospital
Eligibility
Inclusion criteria
Inclusion criteria: Diagnosis of Schizophrenia: Participants must have a confirmed diagnosis of schizophrenia according to the DSM-5 criteria, with either acute or chronic symptoms that are stable enough to allow participation in the study (without requiring immediate hospitalization). This ensures the study targets the intended population with schizophrenia. Sources: Diagnostic and Statistical Manual of Mental Disorders (DSM-5), American Psychiatric Association, 2013. Age Range: Participants should be aged 18 years or older but not exceeding 60 years, as the app and intervention may be more effective in adults and may not be appropriate for elderly populations with specific health complications. Sources: Velligan et al., 2004; Muench & Hamer, 2010. Ability to Provide Informed Consent: Participants must have the mental capacity to provide informed consent for participation in the study, ensuring they understand the nature of the intervention and their role in the research. This is a standard criterion for all clinical trials. Sources: Ethical guidelines for clinical research, World Health Organization (WHO).
Exclusion criteria
Exclusion criteria: 1. Severe Cognitive Impairment: Participants with significant cognitive impairments, such as those with a Mini-Mental State Examination (MMSE) score lower than 24 or severe executive dysfunction, should be excluded. This ensures that participants can understand and use the mobile app, which may be challenging for those with severe cognitive deficits. 2. Recent Psychiatric Hospitalization or Acute Psychotic Episodes: Participants who have been hospitalized for acute psychosis or severe exacerbations of schizophrenia in the last 30 days should be excluded. Acute episodes could impair their ability to engage with the study intervention effectively. 3. Severe Medical or Neurological Conditions: Participants with significant neurological disorders (e.g., severe epilepsy) or uncontrolled medical conditions (e.g., diabetes, cardiovascular disease) that could interfere with the study or treatment adherence should be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Medication Adherence Rates: Via questionnaires 2.Reduction in Relapse Rates 3.Symptom SeverityTimepoint: 0 weeks,8 weeks,12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Quality of life. 2. Engagement with App.Timepoint: Zero months, one month and three months | — |
Countries
India
Contacts
Public ContactSharni Souganthi S
Saveetha medical college and hospital
Outcome results
None listed